That's why we need and want to understand the broad context in which drug pricing and accessibility operate. The pan-Canadian Pharmaceutical Alliance is key when it comes to speaking about the specific pricing and accessibility of drugs in specific provinces and territories.
The PMPRB is a pricing regulatory board, so it deals with the pricing of patented drugs. However, when those regulations are made, then the drugs and the treatments need to go through CADTH and pCPA. Eventually, they can be used by clinical specialists and patients.